20200120163240asfjn3
20200120163240asfjn3

Gadoterate Meglumine

Product：Gadoterate Meglumine
Indication：gadolinium-based MRI contrast agent
Specification：USP
Regulatory status：US DMF, TW
Packing：1 kg or more
BACK BACK